How new at-home HPV test kits could help Alabama fight cervical cancer
The Food and Drug Administration has approved the country’s first at-home HPV screening kit. That disease causes nearly all cervical cancers. The Alabama Department of Public Health (ADPH) reports Alabama is consistently among the top five states for rates of cervical cancer. While some hope the new kits might turn things around, others have questions.
The new kits, made by Teal Health, come with a swab for collecting vaginal samples, which are then mailed to a lab for screening. Right now, the self-testing kits are only available for use on site at a clinic. And while currently the at-home kits are only being used in California, Alabama officials anticipate that will change.
“HPV self-testing is something that we have been hoping for for a while,” Nancy Wright said.
Wright is the director of ADPH’s Cancer Prevention and Control Division and leader of the state’s Operation Wipeout Cervical Cancer. She noted the kits were approved as potential alternatives to pap smears, which are widely considered uncomfortable and even painful.
“Often embarrassment and discomfort are barriers,” Wright said. “And then, even more importantly, in some of our rural areas, it’s very difficult to get access to that cervical cancer screening and access to care.”
Wright said she hopes the kits will help Alabama not only bring down high cervical cancer rates, but also reach its goal to eliminate cervical cancer entirely by 2034, despite its healthcare deserts.
“We can stop it to where our children and our grandchildren won’t even know what it is,” Wright said. “And we can do this within my lifetime.”
Others see the kits bringing further challenges.
“The thing I’m concerned about is the backstream and downstream sort of management of an abnormal test,” Dr. Warner Huh, chair of UAB’s Department of Obstetrics and Gynecology, said.
He said the at-home kits should be simple to use and studies have shown the results will be accurate. But he questions what happens if a test returns abnormal results.
“Where do they go?” Huh said. “Who sees them? Who’s gonna cover those costs potentially?”
Huh said he does not know for sure if the state can handle evaluating and treating those patients.
“I don’t want people to fall through the cracks knowing that they had an abnormal test and they A, couldn’t see somebody, or B, that there wasn’t someone potentially following up on those results,” Huh said.
He added that treatment is just as important to reducing cervical cancer rates as screening.
Dominion, the voting tech company at the center of false 2020 claims, is sold
Dominion Voting Systems, the company at the center of false fraud claims about the 2020 election, has been acquired by an entity called Liberty Vote.
Justice Department indicts Letitia James after pressure from Trump
The indictment comes after steady pressure from President Trump to prosecute James, who successfully sued Trump and his company for inflating the value of some of its properties.
Once the Gaza ceasefire goes into effect, what happens next? Here’s what to know
Israel and Hamas have reached an agreement for the "first phase" of a plan promoted by President Trump to end the war in Gaza. A ceasefire is expected to go into effect after an Israeli Cabinet vote.
Despite stiff opposition, Bessemer changes its laws to accommodate data centers
Residents in and around Bessemer expressed continued disapproval of a plan to build a 14.5 million square foot data center in their back yards. Now, the city is one step closer to final approval.
This #MeToo melodrama isn’t great, but Julia Roberts’ performance is
Roberts plays a Yale professor whose life unravels after one of her colleagues is accused of sexually assaulting a student. After the Hunt is an academic potboiler that muddles its central issue.
What to know about the Nobel Peace Prize
Anticipation is growing and bookies around the world are taking bets on who'll be awarded this year's Nobel Peace Prize. Here is what to know ahead of the award announcement this week.
